Atlas Trials

Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC

Clinical trial NCT03998085 · UNKNOWN

Trial details

NCT number
NCT03998085
Sponsor
The First Hospital of Jilin University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2019-03-05
Primary completion
2020-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.